Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medicis snags Graceway in $455 mln bankruptcy sale
Reuters
Friday, November 18, 2011 - 11:46am
tags:
Medicis, Galderma, Graceway, M&A
Regeneron And Amgen: More Breakthrough Drugs On The Horizon
Seeking Alpha
Friday, November 18, 2011 - 11:45am
tags:
Amgen, Regeneron, AMG145, PCSK9 inhibitor
Par Pharma Takes Over Anchen Pharma
Yahoo/Zacks.com
Friday, November 18, 2011 - 11:43am
tags:
Par Pharmaceutical, M&A, Anchen
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Seeking Alpha
Friday, November 18, 2011 - 11:42am
tags:
Intellipharmaceutics, generics, Pfizer, AstraZeneca, Novartis, Bristol-Myers Squibb
EU backs Boehringer's Pradaxa despite 256 deaths
Reuters
Friday, November 18, 2011 - 11:41am
tags:
Boehringer Ingelheim, Europe, Pradaxa, bloodthinners
AstraZeneca: Saturn Trial Will Hamper Revenue Growth
Seeking Alpha
Friday, November 18, 2011 - 11:40am
tags:
SATURN, Pfizer, AstraZeneca, Crestor, Lipitor, statins
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Motley Fool
Friday, November 18, 2011 - 11:39am
tags:
EMA, AstraZeneca, medullary thyroid cancer, vandetanib
Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Friday, November 18, 2011 - 11:37am
tags:
Dendreon, Provenge, JNJ, prostate cancer
Pfizer: Investors Should Now Focus On Its Pipeline
Seeking Alpha
Friday, November 18, 2011 - 11:06am
tags:
Pfizer
Pfizer near agreement to resolve bribery probe
Fierce Pharma
Thursday, November 17, 2011 - 12:59pm
tags:
Pfizer, bribery, SEC, Wyeth
How Fast Is the Cash at Sequenom?
Motley Fool
Thursday, November 17, 2011 - 12:57pm
tags:
cash, Sequenom
1 Reason Johnson & Johnson's Earnings Aren't So Hot
Motley Fool
Thursday, November 17, 2011 - 12:53pm
tags:
JNJ, earnings
Why Merck's Fair Value Is $46 Per Share
Seeking Alpha
Thursday, November 17, 2011 - 12:52pm
tags:
Merck
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
Thursday, November 17, 2011 - 9:09am
tags:
FDA, myelofibrosis, bone marrow disorder, Jakafi, JAK inhibitors, Incyte
Pfizer Strikes Pharmacy Deals to Hold Lipitor Sales
Bloomberg
Thursday, November 17, 2011 - 9:06am
tags:
statins, pharmacies, Pfizer, Lipitor, Express Scripts
Sanofi's Multaq will no longer be reimbursed in France
Reuters
Thursday, November 17, 2011 - 9:05am
tags:
Sanofi, France, Euripe, Multaq
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thursday, November 17, 2011 - 9:03am
tags:
Alnylam, Dendreon, GSK, Medivation, ImmunoCellular, Novartis, cancer, NewLink Genetics
FDA grants priority review to Chelsea's hypotension drug
Reuters
Thursday, November 17, 2011 - 9:01am
tags:
FDA, Chelsea Therapeutics, hypotension, Northera
Meda Agrees to Buy Three Drugs From J&J for $110.5 Million
Bloomberg
Thursday, November 17, 2011 - 9:00am
tags:
Meda, JNJ, OTC
Pfizer's rare disease drug gets EU nod
Reuters
Thursday, November 17, 2011 - 8:58am
tags:
Pfizer, Europe, Vyndaqel, transthyretin familial amyloid polyneuropathy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.